Harvard medical school in ethics quandary
New York Times, March 3, 2009
A full-blown movement by more than 200 Harvard Medical School students and sympathetic faculty is intent on exposing and curtailing drug industry influence in their classrooms and laboratories, as well as in Harvard's 17 affiliated teaching hospitals and institutes. They say they are concerned that the same money that helped build the school's world-class status may in fact be hurting its reputation and affecting its teaching. The students argue, for example, that Harvard should be embarrassed by the F grade it recently received from a national group that rates how well medical schools monitor and control drug industry money.
Most Viewed
Most Emailed
- Urologists 'Outraged' Over PSA Test Challenge
- New Facebook Page Gathers Stories of Medical Harm
- Luxury Hospital Facilities Put Patient Experience First
- Five Hospitals Share Three Secrets to Improve Knee Surgery Outcomes
- Heartland Health Joins Mayo Clinic Network
- Beleaguered Fairview Health CEO to Retire in July
- Health Insurance Exchanges Put Defined Benefits to the Test
- Challenging Physicians to Help Improve the ED
- For hospitals and insurers, new fervor to cut costs
- The Power of Plugged-In Physicians

